×ÉѯÈÈÏß
18616108315
18616108315
²úÎï·ÖÀà
Product CategoryÏêϸ½éÉÜ
| Æ·ÅÆ | ³¢¾±´Ú±ð-¾±³¢²¹²ú/Àî¼ÇÉúÎï |
|---|
K7M2 WT£¨Ð¡Êó¹ÇÈâÁö³É¹Çϸ°û£©ÃèÊö
K7M2 WT £¨ÖÐÎÄÃû³Æ£ºÐ¡Êó¹ÇÈâÁö³É¹Çϸ°û£©£¬À´Ô´ÓÚСÊó¹ÇÈâÁö³É¹Çϸ°û£¬Õý³£µÄϸ°ûÐÎ̬Ϊ³É¹Çϸ°ûÑù£¬Ìù±ÚÉú³¤¡£
¶©¹ºÐÅÏ¢
²úÎïÃû³Æ | »õºÅ | ¹æ¸ñ |
K7M2 WT | AX31L583 | T25/1mL |
ÔËÊ䷽ʽ
³£ÎÂ/¸É±ùÔËÊä¡£
K7M2 WT£¨Ð¡Êó¹ÇÈâÁö³É¹Çϸ°û£©Ê¹Ó÷½·¨
ÅàÑø·½·¨
ÅàÑø»ù | DMEM£¨GIBCO: C11965500BT£©90%, Fetal Bovine Serum (¸ßÆ·ÖÊ̥ţѪÇå) »òºÍÔªÀî¼ÇÌؼ¶Ì¥Å£ÑªÇå (Foetal Bovine Serum)£¨»õºÅ£ºAC03L055£© 10% |
ÅàÑøÌõ¼þ | 37¡æ 5% CO2 |
Ïû»¯Ìõ¼þ | 0.25% (w/v) Trypsin-0.53 mM EDTAÈÜÒº£¬Ïû»¯1-2min |
´«´ú±ÈÀý | 1£º4-1£º6 |
»»ÒºÊ±¼ä | ÿÖÜ»»Òº2-3´Î |
¶³´æ·½·¨
¶³´æÒº | 55%ÅàÑø»ù£¬40%FBS, 5% (v/v) DMSO»ò ºÍÔªÀî¼Ç¿ìËÙϸ°û¶³´æÒº£¨ÎÞѪÇå¡¢ÎÞµ°°×£©£¨»õºÅ£ºAC05L033£© |
¶³´æÃÜ¶È | 1-3 ¡Á106 /¹Ü£¬Òºµª±£´æ |
¾ßÌå²Ù×÷·½·¨¼ûϸ°ûʹÓÃ˵Ã÷Êé
×¢ÒâÊÂÏî
±¾²úÎï½öÏÞÓÚ¿ÆѧʵÑéÑо¿Ê¹Ó㬲»µÃÓÃÓÚÁÙ´²Õï¶Ï¡¢ÖÎÁƵÈÁìÓò¡£
µ±ÊÕµ½Ï¸°ûºó£¬Çë×ÐϸÔĶÁϸ°ûʹÓÃ˵Ã÷Ê飬°´¹æ¶¨²Ù×÷²¢¼Ç¼ϸ°û״̬£¨ÅÄÕÕ£©¡£ÎÒ˾Ϊ¿Í»§ÌṩһÖÜÄÚµÄÊÛºó±£ÕÏ¡£
²Î¿¼ÎÄÏ×
Khanna C, et al. An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin. Exp. Metastasis 18: 261-271, 2000. PubMed: 11315100
Khanna C, et al. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res. 61: 3750-3759, 2001. PubMed: 11325848
Khanna C, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat. Med. 10: 182-186, 2004. PubMed: 14704791
±¾²úÎï½öÏÞÓÚ¿ÆѧʵÑéÑо¿Ê¹Ó㬲»µÃÓÃÓÚÁÙ´²Õï¶Ï¡¢ÖÎÁƵÈÁìÓò¡£
²úÎï×Éѯ
΢ÐÅ×Éѯµç»°
΢ÐÅ×Éѯ
¹Ø×¢¹«ÖÚºÅ
µ±Ç°Î»Öãº
